Exhibit 107


Calculation of Filing Fee Tables


Form S-1

(Form Type)


Propanc Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)


Table 1: Newly Registered and Carry Forward Securities


   Security Type   Security Class Title   Fee Calculation or Carry Forward Rule   Amount To Be Registered   Maximum Offering Price Per Share   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee   Carry Forward Form Type   Carry Forward File Number   Carry Forward Initial Effective Date   Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward 
Newly Registered Securities 
Fees to be paid   Equity    Common stock, $0.001 par value per share    Rule 457(c)    26,250,000 (1)(3)    $0.05255 (2)   $1,379,437.50    0.00011020   $152.01                     
Fees Previously Paid                                                     
Carry Forward Securities 
Carry Forward Securities                                                   
Total Offering Amounts   $1,379,437.50        $152.01                     
Total Fees Previously Paid                                   
Total Fee Offset                                   
Net Fee Due             $152.01                     


(1)Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), includes any additional shares of common stock, par value $0.001 per share (the “Common Stock”), of Propanc Biopharma, Inc. (the “Registrant”) that may from time to time be offered or issued to prevent dilution from any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock.


(2)Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share of Common Stock as reported on August 8, 2023 on the Pink® Open Market operated by the OTC Markets Group Inc., which date is a date within five business days of the filing of the registration statement filed by the Registrant for the registration of the shares of Common Stock listed in the table above (the “Registration Statement”).


(3)Represents shares of Common Stock registered for resale on this registration statement by the selling securityholders named in this registration statement or their permitted transferees. Such number of shares of Common Stock is a portion of the maximum number of shares of Common Stock that may be issued by the Company from time to time to the selling stockholder named in the Registration Statement pursuant to the common stock purchase agreement, dated July 20, 2023, entered into by and between the Registrant and such selling stockholder.